Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HITI
1876
High Tide
HITI
$206M
| $2.59M | ﹤0.01% |
839,600
+493,300
| +142% | +$1.4M |
|
1877
Bar Harbor Bankshares
BHB
$681M
| $2.59M | ﹤0.01% |
84,684
+1,000
| +1% | +$33.1K |
|
1878
China Yuchai International
CYD
$1.7B
| $2.58M | ﹤0.01% |
270,994
-19,100
| -7% | -$201K |
|
1879
iShares S&P 500 Value ETF
IVE
$50.3B
| $2.58M | ﹤0.01% |
13,500
-9,200
| -41% | -$1.82M |
|
1880
Cousins Properties
CUZ
$4.89B
| $2.57M | ﹤0.01% |
84,031
+74,931
| +823% | +$2.3M |
|
1881
Eton Pharmaceutcials
ETON
$1.61B
| $2.57M | ﹤0.01% |
193,100
+109,700
| +132% | +$1.11M |
|
1882
XP
XP
$8.17B
| $2.57M | ﹤0.01% |
+217,000
| New | +$3.42M |
|
|
API
1883
Agora
API
$392M
| $2.57M | ﹤0.01% |
618,000
-136,500
| -18% | -$560K |
|
|
CDTX
1884
DELISTED
Cidara Therapeutics
CDTX
| $2.57M | ﹤0.01% |
95,617
-2,200
| -2% | -$35.7K |
|
1885
Vanguard Morningstar Large-Cap ETF
VV
$54.8B
| $2.56M | ﹤0.01% |
9,500
+5,800
| +157% | +$1.57M |
|
1886
Vanguard ESG US Stock ETF
ESGV
$13.7B
| $2.56M | ﹤0.01% |
24,400
+18,500
| +314% | +$1.94M |
|
1887
AnaptysBio
ANAB
$1.73B
| $2.56M | ﹤0.01% |
193,200
-7,200
| -4% | -$174K |
|
1888
Bank of Marin Bancorp
BMRC
$458M
| $2.56M | ﹤0.01% |
107,492
-52,987
| -33% | -$1.25M |
|
1889
Burford Capital
BUR
$960M
| $2.55M | ﹤0.01% |
200,300
+110,300
| +123% | +$1.48M |
|
1890
Instil Bio
TIL
$50.1M
| $2.55M | ﹤0.01% |
133,755
+36,900
| +38% | +$1.13M |
|
|
FBRT
1891
Franklin BSP Realty Trust
FBRT
$670M
| $2.55M | ﹤0.01% |
203,600
-18,300
| -8% | -$237K |
|
1892
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.9B
| $2.55M | ﹤0.01% |
+71,200
| New | +$2.66M |
|
1893
Smith Douglas Homes
SDHC
$117M
| $2.54M | ﹤0.01% |
99,200
+24,000
| +32% | +$798K |
|
1894
Hingham Institution for Saving
HIFS
$680M
| $2.54M | ﹤0.01% |
9,989
-700
| -7% | -$186K |
|
1895
Agree Realty
ADC
$9.3B
| $2.54M | ﹤0.01% |
+36,000
| New | +$2.68M |
|
1896
Energy Fuels
UUUU
$3.77B
| $2.54M | ﹤0.01% |
+494,353
| New | +$3.06M |
|
1897
Eagle Bancorp
EGBN
$878M
| $2.53M | ﹤0.01% |
97,380
-12,500
| -11% | -$335K |
|
1898
Compass Minerals
CMP
$1.11B
| $2.53M | ﹤0.01% |
225,200
-322,800
| -59% | -$4.22M |
|
1899
Annexon
ANNX
$867M
| $2.53M | ﹤0.01% |
493,700
+92,300
| +23% | +$568K |
|
1900
Mirion Technologies
MIR
$3.96B
| $2.53M | ﹤0.01% |
145,014
+32,014
| +28% | +$497K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.